Escribá María-José, Bellver José, Bosch Ernesto, Sánchez María, Pellicer Antonio, Remohí José
Universitary Institute IVI Valencia, Valencia, Spain.
Fertil Steril. 2006 Jul;86(1):92-7. doi: 10.1016/j.fertnstert.2005.12.048.
To determine whether the initiation of P supplementation as artificial luteal phase support (day -1, day 0, or day +1 of egg donation) in extensive programs of ovum donation influences cycle cancellation, pregnancy outcome, and implantation rate in day 3 embryo transfers.
Prospective randomized trial.
Oocyte donation program at the Instituto Valenciano de Infertilidad, Valencia, Spain.
PATIENT(S): Three hundred recipients with normal ovarian function, absence of uterine anomalies, and undergoing their first egg donation were recruited between September 2003 and September 2004.
INTERVENTION(S): A computer-based randomization divided the recipients into three groups when hCG was administered to their matched donors. The first group (group A) started P supplementation the day before oocyte retrieval; the second group (group B) started P supplementation on the day of the oocyte retrieval; and the third group (group C) started P supplementation 1 day after the egg retrieval once fertilization was confirmed.
MAIN OUTCOME MEASURE(S): Implantation, pregnancy, and ongoing pregnancy rates were the primary outcome measures considered. The secondary outcome measure was the cancellation rate, especially due to fertilization failure.
RESULT(S): Global cancellation rate and cancellation rate due to fertilization failure were significantly higher in group A (12.4% and 8.2%, respectively) than in group C (3.3% and 0%, respectively). Reproductive outcome was similar in all the groups except for a higher biochemical pregnancy rate in group A (12.9%) than in groups B (6.6%) and C (2.3%).
CONCLUSION(S): Initiation of P on day +1 of embryo development decreases cancellation rates of day 3 embryo transfers in extensive programs of ovum donation without any deleterious effect on pregnancy outcome or implantation rate.
确定在广泛的卵子捐赠计划中,作为人工黄体期支持(卵子捐赠的第 -1 天、第 0 天或第 +1 天)开始补充孕激素是否会影响第 3 天胚胎移植的周期取消率、妊娠结局和着床率。
前瞻性随机试验。
西班牙巴伦西亚市巴伦西亚不育症研究所的卵子捐赠项目。
2003 年 9 月至 2004 年 9 月期间招募了 300 名卵巢功能正常、无子宫异常且首次接受卵子捐赠的受者。
当向其匹配的供体注射 hCG 时,通过计算机随机分组将受者分为三组。第一组(A 组)在取卵前一天开始补充孕激素;第二组(B 组)在取卵当天开始补充孕激素;第三组(C 组)在确认受精后取卵后 1 天开始补充孕激素。
着床率、妊娠率和持续妊娠率是主要考虑的观察指标。次要观察指标是取消率,尤其是因受精失败导致的取消率。
A 组的总体取消率和因受精失败导致的取消率(分别为 12.4%和 8.2%)显著高于 C 组(分别为 3.3%和 0%)。除 A 组的生化妊娠率(12.9%)高于 B 组(6.6%)和 C 组(2.3%)外,所有组的生殖结局相似。
在胚胎发育第 +1 天开始补充孕激素可降低广泛卵子捐赠计划中第 3 天胚胎移植的取消率,且对妊娠结局或着床率无任何有害影响。